Crohn's disease is one of the most prevalent types of Inflammatory bowel diseases characterized by abdomina...
TLX66 Meets Study Objectives, Holding Out in AL AmyloidosisTelix Pharmaceuticals reported the results from the TRALA trial (Targeted Radiotherapy for AL Amyloidosis), a Phase I/IIa trial evalu...
InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in ChinaInnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today...
Adagio Raises $336 Million to Advance Covid-19 Antibody TreatmentAn antibody startup Adagio Therapeutics announced the completion of a $336 million Series C financing round. The proceedings fr...
Alpha1-antitrypsin deficiency (AATD) was first identified by Carl-Bertil Laurell and Sten Eriksson (Laurell and Eriksson 1963) in 1963, who discovered a link between low plasma serum AAT lev...
Artificial intelligence and robotics are the two technologies that have shown the potential to address and provide solutions to many contemporary issues. The manufacturing sector has been using ro...
Verily collaborates with Janssen to launch COVID-19 immune response studyVerily is partnering with Johnson & Johnson’s Janssen division to witness the body’s earliest immune responses to a...
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
